ReviewHeliyon2022
The therapeutic potential of
Review in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Mechanistic Insights into Houttuynia cordata Thunb. as a Potential Therapeutic Strategy Targeting Metabolic Disorders in Preclinical Models.Current nutrition reports · 2026Review
- Herbal preparations traditionally used in upper respiratory tract infections: UHPLC-DAD-ESI-MS/MSBMC complementary medicine and therapies · 2026Article
- Anti-inflammatory and polarization-modulating effects ofJournal of traditional and complementary medicine · 2026Article
- Review
- Alleviation of tissue adhesion using dual-functional methacrylated gelatin via immunomodulation and antifibrotic activity.Frontiers in immunology · 2026Article
- Geographical Variation Shapes Nutritional Metabolite Profile and Food Functionality ofMetabolites · 2025Article
- In vitro bioactivities and formulation stability of Houttuynia cordata essential oil for cosmetic applications.Scientific reports · 2025Article
- Natural Compounds with Antiviral Activity Against Clinically Relevant RNA Viruses: Advances of the Last Decade.Biomolecules · 2025Review
- Article
- Antiviral treatment for viral pneumonia: current drugs and natural compounds.Virology journal · 2025Review
- Thyroid Stimulatory Activity ofNutrients · 2025Article
- Unraveling the Core Components and Critical Targets ofCurrent pharmaceutical design · 2025Article
- Effects of summer supplementation ofFrontiers in veterinary science · 2025Article
- Antibacterial activity and mechanism of Sodium houttuyfonate against heteroresistantFrontiers in microbiology · 2025Article
- Research Progress on the Chemical Constituents and Pharmacological Effects ofCurrent issues in molecular biology · 2024Review
- Genotoxic and Anti-Genotoxic Assessments of FermentedFoods (Basel, Switzerland) · 2024Article
- A near-complete assembly of the Houttuynia cordata genome provides insights into the regulatory mechanism of flavonoid biosynthesis in Yuxingcao.Plant communications · 2024Article
- Impacts of Plu kaow (Antioxidants (Basel, Switzerland) · 2024Article
- Inhibitory Efficacy of Main Components ofInternational journal of molecular sciences · 2024Article
- Evaluating Antioxidant Performance, Biosafety, and Antimicrobial Efficacy ofAntioxidants (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The search and development of new drugs for the treatment of numerous illnesses afflicting humans of all ages is an unending endeavour. Moreover, there is constant demand to identify more compounds exhibiting pharmacological properties with improved efficacy and minimal side effects compared to the existing ones. Plants have always served as rich sources of pharmaceuticals, and offer better advantages than synthetic compounds in terms of diversity, production scale and safety.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.